Ashurst advised Jefferies, as sole bookrunner, in relation to an accelerated book build private placement of new shares by Kiadis Pharma N.V., a clinical stage biopharmaceutical…
Kiadis Pharma N.V.’s €18 million private placement of new shares
Ashurst advised Jefferies, as sole bookrunner, in relation to an accelerated book build private placement of new shares by Kiadis Pharma N.V., a clinical stage biopharmaceutical…